A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This is a safety and efficacy study of abicipar pegol in patients with neovascular
age-related macular degeneration to establish comparability between Japanese and
non-Japanese.